Jacques Galipeau

18PUBLICATIONS
48CO-AUTHORS
Molecular targetsAutoimmunityInnate immunityCancer diagnosisPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|May 18, 2026
An autologous cell-based therapeutic vaccine expressing IL6/1 fusokine drives robust anti-tumor response against ovarian cancer.

|May 07, 2026
The oxidative phosphorylation inhibitor, atovaquone, upregulates PD-L1 via activation of the ATM/ATR DNA damage response pathway.

|Apr 17, 2026
Extracellular vesicles mediate intercellular transfer of PD-L1 and bystander T-cell suppression.

|Dec 31, 2025
Regulatory B cell CCL3 competency promotes disease resolution and oligodendrogenesis in experimental autoimmune encephalomyelitis.

Andrea Pennati, Xingyi Tang, Catigan Hedican

|Dec 05, 2025
Combined innate immune cell therapy, tumor-specific antibody, and radiation prompt antitumor response in pancreatic cancer models.

Md Mahfuzur Rahman, Andrea Pennati, Tavus Atajanova

|Nov 16, 2022
CTR9 drives osteochondral lineage differentiation of human mesenchymal stem cells via epigenetic regulation of BMP-2 signaling.

Ngai Ting Chan, Ming-Song Lee, Yidan Wang

Pageof 3

Frequent Collaborators

4 joint publications

Andrea Pennati

2 joint publications

Srikant Rangaraju

2 joint publications

Manish S Patankar

2 joint publications

Md Mahfuzur Rahman